Healthcare Services

Transcriptomics Market Growth to $10.29 Billion by 2030 at 7.8% CAGR

April 28, 2026April 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Transcriptomics Market Be By 2030 Compared To Its 2026 Market Size?

The transcriptomics market size has demonstrated significant expansion in recent years. It is anticipated to increase from $7.04 billion in 2025 to $7.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.1%. This past growth can be attributed to enhancements in sequencing technologies, a reduction in the cost of high-throughput analysis, the broadening of academic genomics research, the presence of standardized transcriptomic workflows, and an increase in life sciences funding.

The transcriptomics market size is projected to experience substantial expansion in the coming years. This market is set to reach $10.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. The projected growth during this period stems from factors such as the increasing incorporation of AI-driven data analysis, the escalating demand for personalized therapeutics, the broadening scope of clinical transcriptomics applications, growing financial commitments to omics research infrastructure, and the heightened adoption of transcriptomic profiling within the pharmaceutical sector. Key trends anticipated for the forecast period encompass a wider uptake of RNA sequencing technologies, expanding utilization of single-cell transcriptomics, the enlargement of bioinformatics and data analytics platforms, an increasing need for biomarker discovery applications, and a sharpened emphasis on precision medicine.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24417&type=smp

Which Strong Drivers Are Impacting The Transcriptomics Market Growth?

The growing acceptance of personalized medicine is anticipated to drive the expansion of the transcriptomics market moving forward. Personalized medicine defines a medical strategy that customizes patient care based on an individual’s genetic profile, lifestyle, and surrounding environment. This approach is gaining traction due to advancements in genetic sequencing, which allows for treatments precisely tailored to individual genetic profiles, leading to greater effectiveness. Transcriptomics plays a crucial role by uncovering individual gene expression profiles, thereby guiding personalized treatments informed by a patient’s unique biological makeup. This contributes to enhanced therapeutic efficacy, minimized side effects, and facilitates earlier disease diagnosis. For instance, in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care organization, stated that the FDA approved 16 new personalized treatments for rare disease patients in 2023, a significant rise from six in 2022. Thus, the escalating adoption of personalized medicine is serving as a key driver for the growth of the transcriptomics market.

How Is The Transcriptomics Market Categorized Across Its Segment Groups?

The transcriptomics market covered in this report is segmented –

1) By Type: Instruments, Consumables, Software, Services

2) By Technology: Micro Array, Real-Time Quantitative Polymerase Chain Reaction, Sequencing Technologies

3) By Application: Diagnostics And Disease Profiling, Drug Discovery, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Other End-Users

Subsegments:

1) By Instruments: Microarray Instruments, Sequencing Instruments, Polymerase Chain Reaction (PCR) Instruments, Other Transcriptomics Instruments

2) By Consumables: Reagents, Probes, Kits, Chips

3) By Software: Data Analysis Software: Data Management Software, Visualization Software: Bioinformatics Software

4) By Services: Data Analysis Services, Sample Preparation Services, Sequencing Services, Consulting Services

Which Trends Are Contributing To Changes In The Transcriptomics Market?

Leading firms within the transcriptomics market are concentrating their efforts on creating sophisticated offerings, including single-cell spatial panels, to gain more profound understanding of cellular operations and disease pathways. These single-cell spatial panels facilitate the analysis of gene expression down to the individual cell level, critically preserving the spatial context of each cell within its tissue environment. By integrating single-cell transcriptomics with spatial information, they provide valuable insights into both the activity of cells and the overall architecture of tissues. As an illustration, in February 2024, NanoString Technologies, a biotechnology firm based in the US, introduced the CosMx 6,000 plex RNA Assay, which functions as a spatial molecular imaging assay. This introduction signifies the market debut of the industry’s inaugural single-cell spatial panel, engineered to quantify over 6,000 RNA targets spanning almost all human biological pathways. This innovative advancement, intended for application with the CosMx Spatial Molecular Imager (SMI), empowers researchers to conduct gene profiling with single-cell and subcellular precision, ensuring high accuracy and sophisticated cell segmentation capabilities.

Which Firms Are Influencing Competition In The Transcriptomics Market?

Major companies operating in the transcriptomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Genewiz Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Singleron Biotechnologies, SCIEX, CD Genomics Inc., Parse Biosciences Inc., Lexogen GmbH, LC Sciences LLC, Arraystar Inc.

Get The Full Transcriptomics Market Report:

https://www.thebusinessresearchcompany.com/report/transcriptomics-global-market-report

Which Region Accounts For The Largest Portion Of The Transcriptomics Market?

North America was the largest region in the transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Transcriptomics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/transcriptomics-global-market-report

Browse Through More Reports Similar to the Global Transcriptomics Market 2026, By The Business Research Company

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Pharmacogenomics Market Report

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Rna Sequencing Services Market Report

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795